drugset / Trial / NCT06652958

A Study to Assess the Safety and Pharmacokinetics of a Human Monoclonal Antibody (VH4527079) in Healthy Adults and Persons With HIV

NCT06652958 ↗

Phase 1 Active not recruiting 102 enrolled ViiV Healthcare
Non-randomizedSequentialOpen-labelTreatment

Summary

This study evaluates the safety, tolerability, and pharmacokinetics (PK) of a single dose administration of VH4527079 by subcutaneous (SC) injection or by intravenous (IV) infusion in healthy adult participants and multiple dose administration by IV infusion in healthy adult participants and in Persons with HIV (PWH).

Timeline

Start
2024-10-02
Primary completion
2026-09-09
Completion
2026-09-09

Drugs

EvaluationDrugModalityDoseRoute
Subject VH4527079 Monoclonal antibody — Subcutaneous